OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ITHD.PSX56

Ittehad Chemicals Ltd

Commodity ChemicalsVerified

The company's capital structure shows a debt-to-equity ratio of 0.53, indicating a moderate reliance on debt financing. Its liquidity position is characterized by a current ratio of 1.05, suggesting limited short-term liquidity cushion. Free cash flow is negative at -669.2 million PKR, and capital expenditures are significant at -2.37 billion PKR, reflecting ongoing investment in operations. Profitability metrics show a return on equity (ROE) of 12.62% and a return on assets (ROA) of 6.4%, both above the typical thresholds for the Commodity Chemicals industry. However, the company's operating margin is constrained by high capital expenditures and negative free cash flow, which may affect long-term sustainability. Geographically, Ittehad Chemicals is concentrated in Pakistan, with no disclosed international revenue streams. Its primary revenue comes from the sale of caustic soda and surfactants, with no material diversification across product lines or markets. This concentration increases exposure to local economic and regulatory conditions. The company's growth trajectory is mixed. Revenue for the latest period is reported at 27.86 billion PKR, but there is no disclosed year-over-year growth rate. The outlook for the current fiscal year is neutral, with no significant revenue or margin expansion expected. The next fiscal year is projected to show similar performance, with no material changes in operating income or net income. Risk factors include medium liquidity risk due to a current ratio near 1.0 and negative free cash flow. The company also faces potential dilution, though the risk is currently assessed as low. No recent equity issuance or dilutive events have been disclosed, and the company's capital structure remains stable. Recent events include the company's ongoing operations in the chlor-alkali and surfactant markets, with no material changes in business strategy or regulatory environment. The company's subsidiary, Ittehad Salt Processing (Private) Limited, continues to operate in the mining and quarrying sector, contributing to the company's diversified but limited asset base.

30-day price · ITHD.PSX+27.08 (+23.3%)
Low$110.03High$164.89Close$143.48As of15 May, 00:00 UTC
Profile
CompanyIttehad Chemicals Ltd
TickerITHD.PSX
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Ittehad Chemicals Ltd is a Pakistan-based company engaged in the manufacturing and sale of caustic soda and allied chemicals, including surfactants such as Linear Alkylbenzene Sulfonic Acid (LABSA) and Sodium Lauryl Ether Sulfate (SLES), used in industries like agriculture, beverages, and oil and gas drilling.

Classification. Ittehad Chemicals Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92.

The company's capital structure shows a debt-to-equity ratio of 0.53, indicating a moderate reliance on debt financing. Its liquidity position is characterized by a current ratio of 1.05, suggesting limited short-term liquidity cushion. Free cash flow is negative at -669.2 million PKR, and capital expenditures are significant at -2.37 billion PKR, reflecting ongoing investment in operations. Profitability metrics show a return on equity (ROE) of 12.62% and a return on assets (ROA) of 6.4%, both above the typical thresholds for the Commodity Chemicals industry. However, the company's operating margin is constrained by high capital expenditures and negative free cash flow, which may affect long-term sustainability. Geographically, Ittehad Chemicals is concentrated in Pakistan, with no disclosed international revenue streams. Its primary revenue comes from the sale of caustic soda and surfactants, with no material diversification across product lines or markets. This concentration increases exposure to local economic and regulatory conditions. The company's growth trajectory is mixed. Revenue for the latest period is reported at 27.86 billion PKR, but there is no disclosed year-over-year growth rate. The outlook for the current fiscal year is neutral, with no significant revenue or margin expansion expected. The next fiscal year is projected to show similar performance, with no material changes in operating income or net income. Risk factors include medium liquidity risk due to a current ratio near 1.0 and negative free cash flow. The company also faces potential dilution, though the risk is currently assessed as low. No recent equity issuance or dilutive events have been disclosed, and the company's capital structure remains stable. Recent events include the company's ongoing operations in the chlor-alkali and surfactant markets, with no material changes in business strategy or regulatory environment. The company's subsidiary, Ittehad Salt Processing (Private) Limited, continues to operate in the mining and quarrying sector, contributing to the company's diversified but limited asset base.
Key takeaways
  • Ittehad Chemicals Ltd operates in the Commodity Chemicals industry with a moderate debt-to-equity ratio and limited liquidity cushion.
  • The company's ROE and ROA are above industry norms, but negative free cash flow and high capital expenditures may constrain long-term growth.
  • Revenue is concentrated in Pakistan, with no material international diversification, increasing exposure to local economic conditions.
  • The company's growth outlook is neutral, with no significant revenue or margin expansion expected in the near term.
  • Liquidity risk is moderate, and dilution risk is low, with no recent equity issuance or dilutive events disclosed.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyPKR
Revenue$27.86B
Gross profit$4.99B
Operating income$2.85B
Net income$1.29B
R&D
SG&A
D&A
SBC
Operating cash flow$986.7M
CapEx-$2.37B
Free cash flow-$669.2M
Total assets$20.16B
Total liabilities$9.93B
Total equity$10.23B
Cash & equivalents
Long-term debt$5.44B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$10.23B
Net cash-$5.44B
Current ratio1.1
Debt/Equity0.5
ROA6.4%
ROE12.6%
Cash conversion76.0%
CapEx/Revenue-8.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricITHD.PSXActivity
Op margin10.2%0.4% medp25 -8.0% · p75 16.0%above median
Net margin4.6%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin17.9%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-8.5%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity53.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 03:53 UTC#f65eb381
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 03:56 UTCJob: e0689f21